Table 3 Patient and clinic determinants of HbA1c, SBP and LDL-C levels in T2D

 Age (years)

− 0.04(− 0.05, − 0.03))

***

0.08(0.01, 0.15)

*

− 0.007(− 0.01, − 0.003)

**

 Male sex

− 0.04(− 0.19, 0.10)

−1.92(−3.22, − 0.63)

**

− 0.05(− 0.12, 0.03)

 Malay ethnicity

0.01(− 0.15, 0.18)

1.85(0.35, 3.35)

*

0.27(0.18, 0.36)

***

 Duration of diabetes (years)

0.05(0.04, 0.07)

***

− 0.09(− 0.21, 0.04)

− 0.01(− 0.02, − 0.003)

**

 Body mass index

0.004(− 0.01, 0.02)

0.06(− 0.06, 0.17)

− 0.01(− 0.02, − 0.004)

**

 HbA1c

–

−0.22(− 0.54, 0.11)

0.07(0.05, 0.09)

***

 SBP

− 0.005(− 0.009, − 0.001)

**

–

0.002(0.0001, 0.004)

*

 LDL-C

0.23(0.16, 0.29)

***

0.67(0.07, 1.26)

*

–

 Hypertension

–

2.64(0.85, 4.43)

**

–

 Hyperlipidaemia

–

–

0.04(−0.04, 0.13)

 Microvascular complication

0.21(0.03, 0.38)

*

1.79(0.19, 3.38)

*

−0.10(− 0.19, − 0.0001)

 Macrovascular complication

− 0.07(− 0.34, 0.20)

−1.23(−3.64, 1.18)

−0.14(− 0.28, 0.01)

 Insulin

1.81(1.65, 1.98)

***

0.25(−1.31, 1.81)

−0.01(− 0.11, 0.08)

 Number of antihypertensive(s)

–

4.43(3.76, 5.10)

***

0.03(−0.01, 0.07)

 ACEI/ARB

0.05(−0.10, 0.20)

–

–

 Statin

−0.06(− 0.24, 0.12)

−2.56(−4.17, − 0.29)

**

−0.01(− 0.11, 0.09)

 Urban geographical location

−0.11(− 0.41, 0.19)

−3.03(−7.12, 1.05)

0.04(− 0.12, 0.19)

 Daily attendances

−0.0003(− 0.001, 0.001)

0.01(− 0.01, 0.02)

0.00003(− 0.0004, 0.0005)

 Family medicine specialist available

−0.05(− 0.40, 0.30)

− 0.41(−5.20, 4.39)

−0.04(− 0.23, 0.14)

 Diabetes educator available

−0.15(− 0.41, 0.12)

0.03(−3.68, 3.73)

− 0.04(− 0.18, 0.10)

 Diabetes medication adherence service available

− 0.04(− 0.40, 0.33)

2.04(−2.99, 7.07)

−0.13(− 0.33, 0.06)

 Deviance^a

12,242

25,193

8551

 Deviance change from empty model

− 900

− 384

− 148